Evopoint Biosciences

CompanyChina

Evopoint Biosciences develops one asset, in phase 1 (XNW5004 in non-Hodgkin lymphoma). Mostly small molecule; based in China.

1
Asset
Furthest stage
Phase 1
2
Trials
1
Signal

Pipeline

1
  • XNW5004

    Phase 1, Small molecule, non-Hodgkin lymphoma, peripheral t cell lymphoma

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials2
  • Signals1
  • Similar companies6

Intelligence